Effect of Young Age (below 40 Years) on Oncologic Outcomes in Lebanese Patients with Breast Cancer: a Matched Cohort Study

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2024 May 4

PMID 38704543

Authors

Eman Sbaity

Hani Tamim

Ghada El-Hajj Fuleihan

Jaber Abbas

Mariam Zahwe

Razan El Sayed

Ali Shamseddine

Affiliations

Soon will be listed here.

Abstract

Background: Developing countries have a significantly higher incidence of breast cancer in patients younger than 40 years as compared to developed countries. This study aimed to examine if young age at diagnosis is an independent prognostic factor for worse survival outcomes in breast cancer as well as the effect of age on Disease-free survival (DFS) and local recurrence free survival (LRFS) after adjusting for various tumor characteristics, local and systemic treatments.

Methods: This is a secondary analysis of prospective cohort of patients from two existing databases. We identified patients with breast cancer aged 40 years or less and we matched them to those older than 40 years. We also matched based on stage and molecular subtypes. In cohort 1, we matched at a ratio of 1:1, while in cohort 2 we matched at a ratio of 1:3.

Results: In cohort 1, Disease-free survival (DFS) at 5 years was significantly shorter for those younger than 40 years (75.6% and 92.7% respectively; p < 0.03). On multivariate analysis, only chemotherapy was found to be significant, while age was not found to be an independent predictor of prognosis. Local recurrence free survival at 5 years was similar between both age categories. Only hormonal therapy is a significant predictor for LRFS at 5 years. In the second cohort, DFS and LRFS at 3 years were similar between those younger and those older than 40 years. On multivariate analysis, no factor including age was found to be an independent predictor of prognosis.

Conclusion: Data in the literature is controversial on the effect of young age on breast cancer prognosis. Our findings could not demonstrate that age is an independent prognostic factor in our population. There is a need for outcomes from larger, prospective series that have longer follow-ups and more data from our region.

Citing Articles

Comparison of clinical characteristics and pathologic complete response rate after neoadjuvant chemotherapy in women under 35 years and older women with breast cancer.

Dou H, Gao T, Li Z, Jia S, Luo D, Ba Y Gland Surg. 2024; 13(11):1907-1920.

PMID: 39678411 PMC: 11635561. DOI: 10.21037/gs-24-293.

References

Gnerlich J, Deshpande A, Jeffe D, Sweet A, White N, Margenthaler J . Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg. 2009; 208(3):341-7. PMC: 3262236. DOI: 10.1016/j.jamcollsurg.2008.12.001. View

AlZaman A, Mughal S, AlZaman Y, AlZaman E . Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain. Saudi Med J. 2016; 37(1):37-42. PMC: 4724677. DOI: 10.15537/smj.2016.1.13016. View

Mehdi I, Abdul Monem E, Jaffar Al Bahrani B, Al Kharusi S, Nada A, Al Lawati J . Age at diagnosis of female breast cancer in Oman: Issues and implications. South Asian J Cancer. 2014; 3(2):101-6. PMC: 4014639. DOI: 10.4103/2278-330X.130442. View

Beadle B, Woodward W, Tucker S, Outlaw E, Allen P, Oh J . Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach. Int J Radiat Oncol Biol Phys. 2008; 73(3):734-44. PMC: 3041273. DOI: 10.1016/j.ijrobp.2008.04.078. View

Kim S, Tran K, MacLean B, Borgen P . Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy. J Am Coll Surg. 1998; 187(1):1-8. DOI: 10.1016/s1072-7515(98)00114-8. View

Nixon A, Neuberg D, Hayes D, Gelman R, Connolly J, Schnitt S . Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol. 1994; 12(5):888-94. DOI: 10.1200/JCO.1994.12.5.888. View

Dafni U, Tsourti Z, Alatsathianos I . Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries. Breast Care (Basel). 2020; 14(6):344-353. PMC: 6940474. DOI: 10.1159/000503219. View

Murphy C, Bartholomew L, Carpentier M, Bluethmann S, Vernon S . Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat. 2012; 134(2):459-78. PMC: 3607286. DOI: 10.1007/s10549-012-2114-5. View

Ahn S, Son B, Kim S, Kim S, Jeong J, Ko S . Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. J Clin Oncol. 2007; 25(17):2360-8. DOI: 10.1200/JCO.2006.10.3754. View

10.

Adami H, Malker B, Meirik O, Persson I, Bergkvist L, Stone B . Age as a prognostic factor in breast cancer. Cancer. 1985; 56(4):898-902. DOI: 10.1002/1097-0142(19850815)56:4<898::aid-cncr2820560433>3.0.co;2-l. View

11.

Xiong Q, Valero V, Kau V, Kau S, Taylor S, Smith T . Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer. 2001; 92(10):2523-8. DOI: 10.1002/1097-0142(20011115)92:10<2523::aid-cncr1603>3.0.co;2-6. View

12.

Oh J, Bonnen M, Outlaw E, Schechter N, Perkins G, Strom E . The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?. Int J Radiat Oncol Biol Phys. 2006; 65(5):1345-52. DOI: 10.1016/j.ijrobp.2006.03.028. View

13.

Dubsky P, Gnant M, Taucher S, Roka S, Kandioler D, Agstner I . Young age as an independent adverse prognostic factor in premenopausal patients with breast cancer. Clin Breast Cancer. 2002; 3(1):65-72. DOI: 10.3816/CBC.2002.n.013. View

14.

Collins L, Marotti J, Gelber S, Cole K, Ruddy K, Kereakoglow S . Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2011; 131(3):1061-6. DOI: 10.1007/s10549-011-1872-9. View

15.

Recht A, Connolly J, Schnitt S, Silver B, Rose M, Love S . The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1988; 14(1):3-10. DOI: 10.1016/0360-3016(88)90043-0. View

16.

Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H . Breast cancer in young women: poor survival despite intensive treatment. PLoS One. 2009; 4(11):e7695. PMC: 2770847. DOI: 10.1371/journal.pone.0007695. View

17.

Fowble B, Schultz D, Overmoyer B, Solin L, Fox K, Jardines L . The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys. 1994; 30(1):23-33. DOI: 10.1016/0360-3016(94)90515-0. View

18.

Kroman N, Holtveg H, Wohlfahrt J, Jensen M, Mouridsen H, Blichert-Toft M . Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer. 2004; 100(4):688-93. DOI: 10.1002/cncr.20022. View

19.

Adami H, Malker B, Holmberg L, Persson I, Stone B . The relation between survival and age at diagnosis in breast cancer. N Engl J Med. 1986; 315(9):559-63. DOI: 10.1056/NEJM198608283150906. View

20.

Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G . Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol. 2002; 13(2):273-9. DOI: 10.1093/annonc/mdf039. View